查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676856

医疗透析设备市场按便携性、组件、模式和最终用户划分 - 全球预测 2025-2030

Medical Hemodiafiltration Machine Market by Portability, Components, Modes, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

医用血液透析设备市场预计在 2024 年达到 8.6684 亿美元，2025 年达到 9.2656 亿美元，到 2030 年将达到 13.0113 亿美元，复合年增长率为 7.00%。

主要市场统计数据
基准年 2024 年 8.6684亿美元
预计 2025 年 9.2656亿美元
预测年份 2030 13亿113万美元
复合年增长率（%） 7.00％

过去十年，医学领域见证了肾臟护理技术的模式转移，血液过滤透析设备的发展就是证据。随着慢性肾臟病盛行率的上升和对以患者为中心的治疗方法的日益重视，现代血液滤过透析设备对于提高治疗的精准度和改善患者预后至关重要。本介绍提供了市场格局的详细概述，追踪了重新定义慢性肾臟病治疗的技术进步、临床效果和创新设计元素的整合。

新研究强调了先进的过滤系统在安全有效地清除血液中的毒素方面发挥的重要作用。在精准医疗和适应性患者特定治疗时代的推动下，製造商现在专注于耐用性、营运效率和临床结果。本报告探讨了工程技术的进步与对透析护理过程的更深入理解如何改变世界各地的病患管理策略。

此外，快速扩大的用户群和对透析设备益处的日益认识正在鼓励医疗保健提供者投资于尖端解决方案。技术创新与临床检验之间的相互作用培育了一个不仅满足现有需求而且预测未来医疗需求的市场。随着临床研究不断检验血液透析滤过的好处，从设计、製造到医疗保健服务的整个价值链上的相关人员都有独特的机会来加强患者照护、减少併发症和优化治疗通讯协定。

医疗透析设备市场的转型

近年来，由于技术突破、动态监管环境和不断发展的患者照护模式的共同作用，医疗血液过滤领域发生了重大变化。外科医生、肾臟科专家和生物医学工程师正在共同努力开发不仅超越以前临床标准而且还引入新变数（如增强的便携性和创新的液体处理机制）的设备。

临床机构越来越认识到将尖端功能整合到血液透析机设备中的好处，包括提高运作可靠性和改善病患安全措施。技术整合（包括即时监控和自动校准）重新定义了服务通讯协定和维护方案，减少了停机时间并更快地提供治疗。此外，对组件小型化的关注为可携式系统铺平了道路，使透析成为偏远地区和居家医疗环境中的可行选择。

设计的演变反映了更广泛的行业趋势：医疗保健的个人化。持续的技术创新不仅满足了患者的迫切需求，也预见了未来治疗模式的改变。研究机构、技术开发商和临床终端使用者之间的协同发展正在加快创新步伐，推动市场持续成长。最终，这些变革将再形成产业，并确保医疗保健提供者能够充分满足当前和未来患者的需求。

血液透析滤过透析设备市场的关键细分见解

細項分析透过关注影响产品开发和市场动态的几个关键标准，提供了对市场的多方面视角。其中一个关键方面是仔细检查便携性，并区分携带式血液过滤装置（为患者提供移动性和灵活性）和固定式血液过滤装置（专为严格控制的临床环境而设计）。这种方法强调了不同患者群体和医疗保健环境的不同需求和使用模式。

另一个富有洞察力的细分是着眼于系统的关键组件。对血泵、透析器和血液透析机过滤器的评估使相关人员能够了解每个模组内的技术挑战和机会。这种基于组件的镜头不仅可以提供维护策略，而且还表明技术升级可以提高性能和临床结果。

市场还根据操作模式对产品进行区分，考虑中稀释、后稀释和预稀释方法。每种模式都有其自身的优势和适应挑战，因此製造商可以根据特定的临床方案和患者要求自订机器。最后，从学术和研究机构、透析诊所、居家医疗机构和医院的最终用户分析中获得了关键见解。这种细分揭示了每个使用者群体的细微偏好，同时也指出了在不断变化的治疗环境中出现的趋势。总的来说，这些细分洞察有助于了解推动市场向前发展至关重要的特定需求和创新机会。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 人们越来越意识到血液透析机相对于传统透析治疗的好处
      • 人口老化需要先进的肾臟护理解决方案
      • 慢性肾臟病盛行率上升导致血液透析机需求增加
    • 限制因素
      • 对机器可靠性和技术问题的担忧正在影响血液透析机的采用
    • 机会
      • 增加研发投入，将物联网及智慧技术融入透析系统
      • 血液透析机创新，实现个人化家庭透析治疗选择
    • 任务
      • 医用血液透析机设备的法规遵循性和认证相关问题
  • 市场区隔分析
    • 便携性：灵活、便捷的治疗选择推动了携带式血液透析机滤过机的使用增加。
    • 最终用户：由于需要大容量、高效和针对患者的治疗能力，透析诊所越来越多地采用血液透析机滤过机。
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 医疗血液透析滤过透析设备市场（按便携性）

  • 可携式血液透析机滤过机
  • 固定式血液透析机过滤装置

第 7 章 医疗血液透析滤过透析设备市场（依组件）

  • 血泵
  • 透析科
  • 血液透析机过滤器

第 8 章 医用血液透析滤过透析设备市场按模式

  • 中度稀释 HDF
  • 后稀释 HDF
  • 预稀释 HDF

第 9 章 医疗血液透析滤过透析设备市场（依最终用户）

  • 学术研究所
  • 透析诊所
  • 居家照护环境
  • 医院

10. 美洲医疗血液过滤透析设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太医疗血液透析滤过透析设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12.欧洲、中东和非洲医疗血液透析滤过透析设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • ARI Medical Technology Co., Ltd.
  • Asahi Kasei Corporation
  • AWAK Technologies Pte. Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • DaVita Inc.
  • Diality, Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Guangzhou MeCan Medical Limited
  • Infomed SA
  • JMS Co. Ltd.
  • Kalstein
  • KNS MEDICAL SAS
  • Medtronic PLC
  • Mozarc Medical Holding LLC
  • Nephro Care India Limited
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • Rockwell Medical, Inc.
  • Shenzhen Landwind Industry Co., Ltd.
  • Soxa Formulations & Research（Pvt.）Ltd.
  • SWS Hemodialysis Care Co., Ltd.
  • Toray Industries, Inc.
  • Wesley Biotech Co., Ltd.
Product Code: MRR-4654A89DBBC1

The Medical Hemodiafiltration Machine Market was valued at USD 866.84 million in 2024 and is projected to grow to USD 926.56 million in 2025, with a CAGR of 7.00%, reaching USD 1,301.13 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 866.84 million
Estimated Year [2025] USD 926.56 million
Forecast Year [2030] USD 1,301.13 million
CAGR (%) 7.00%

The medical landscape has witnessed a paradigm shift in renal care technology over the past decade, and the evolution of hemodiafiltration machines stands as a testament to this transformation. With rising incidences of chronic kidney disease and an increasing emphasis on patient-centric therapeutic modalities, modern hemodiafiltration devices have become fundamental to offering enhanced treatment accuracy and improved patient outcomes. This introduction provides an in-depth overview of the market environment, tracing technological advancements, clinical efficacy, and the integration of innovative design elements that have redefined chronic kidney care.

Emerging research has highlighted the vital role that advanced filtration systems play in ensuring the safe and effective removal of toxins from the bloodstream. Manufacturers are now focusing on durability, operational efficiency, and clinical outcomes, driven by an era that demands precision medicine and adaptive, patient-specific therapies. This report unearths how the combination of engineering advancements and an increased understanding of dialysis care processes promises to revolutionize patient management strategies all around the globe.

Furthermore, the rapidly expanding user base and heightened awareness about the benefits of these machines have encouraged healthcare providers to invest in state-of-the-art solutions. The interplay between technical innovation and clinical validation has fostered a marketplace that not only caters to the existing demand but also anticipates future health care needs. As clinical studies continue to validate the benefits of hemodiafiltration, stakeholders across the value chain-from design and production to healthcare provision-are presented with a unique opportunity to enhance patient care, reduce complications, and optimize treatment protocols.

Transformative Shifts in the Medical Hemodiafiltration Landscape

Recent years have seen transformative shifts in the medical hemodiafiltration landscape, driven by a confluence of technological breakthroughs, dynamic regulatory changes, and evolving patient care models. Surgeons, nephrologists, and biomedical engineers have come together to develop machines that not only surpass previous clinical benchmarks but also introduce new variables such as enhanced portability and innovative fluid handling mechanisms.

Clinical institutions are increasingly acknowledging the benefits of integrating state-of-the-art features into hemodiafiltration machines, ranging from increased operational reliability to improved patient safety measures. Technological integration, including real-time monitoring and automated calibration, has redefined service protocols and maintenance regimens, thereby reducing downtime and expediting the delivery of treatment. Moreover, a heightened focus on the miniaturization of components has paved the way for portable systems, making dialysis a feasible option even in remote or home care settings.

This evolution in design reflects a broader industry trend towards personalization in medical treatment. Continuous innovation not only addresses the immediate needs of patients but also anticipates future shifts in treatment paradigms. Collaboration among research institutions, technology developers, and clinical end users has accelerated the pace of innovation, positioning the market for sustained growth. Ultimately, these transformative shifts are reshaping the industry, ensuring that healthcare providers are well-equipped to meet both current and future patient demands.

Key Segmentation Insights in the Hemodiafiltration Machine Market

The segmentation analysis offers a multidimensional view of the market by looking at several critical criteria that influence product development and market dynamics. One major dimension scrutinizes portability, differentiating between portable hemodiafiltration machines that empower patients with mobility and flexibility, and their stationary counterparts specifically designed for tightly controlled clinical environments. This approach highlights the disparate needs and usage patterns across various patient demographics and healthcare settings.

Another insightful segmentation considers the key components of the systems. The evaluation of blood pumps, dialyzer units, and hemodiafilters has allowed stakeholders to understand technical challenges and opportunities within each module. This component-based lens not only informs maintenance strategies but also hints at where technical upgrades could lead to improved performance and clinical outcomes.

The market also differentiates products based on modes of operation, considering mid-dilution, postdilution, and predilution approaches. Each mode presents its own distinct benefits and adaptation challenges, thus offering manufacturers a pathway to tailor their machines to the specific clinical protocols and patient requirements. Lastly, critical insights have been drawn from the end user analysis, which extends across academic and research institutes, dialysis clinics, home care settings, and hospitals. This segmentation reveals the nuanced preferences of each user group while simultaneously pointing to the emerging trends in treatment environment shifts. Overall, these segmentation insights help in understanding the specific demands and innovative opportunities essential for driving the market forward.

Based on Portability, market is studied across Portable Hemodiafiltration Machines and Stationary Hemodiafiltration Machines.

Based on Components, market is studied across Blood Pumps, Dialyzer Units, and Hemodiafilter.

Based on Modes, market is studied across Mid-dilution HDF, Postdilution HDF, and Predilution HDF.

Based on End User, market is studied across Academic & Research Institutes, Dialysis Clinics, Home Care Settings, and Hospitals.

Key Regional Insights on the Hemodiafiltration Machine Market

An evaluation of the global market reveals distinct regional insights that emphasize dynamic growth opportunities and the influence of healthcare infrastructure on the adoption of hemodiafiltration machines. In the Americas, robust research initiatives, coupled with high healthcare spending and progressive adoption of patient-centered care models, set the stage for rapid market expansion. Meanwhile, regions encompassing Europe, the Middle East & Africa offer a compelling blend of mature health systems and emerging markets, creating a fertile ground for innovations driven by combined public and private investments in healthcare technology.

In Asia-Pacific, accelerating urbanization and a steadily increasing prevalence of chronic conditions are catalyzing demand. This region is characterized by a mix of state-driven healthcare reforms and private sector innovation, which is instrumental in shaping product offerings and market distribution channels. Regional economic and demographic peculiarities intertwine to form unique market dynamics, with each region demanding bespoke strategies to address local challenges and opportunities. These insights underscore the importance of regional customization in product development and market strategy to harness steady growth across diverse geographical landscapes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Hemodiafiltration Landscape

The competitive landscape in the hemodiafiltration machine segment is defined by a host of companies that bring both legacy and innovation to the fore. Prominent players such as ARI Medical Technology Co., Ltd. and Asahi Kasei Corporation lead the charge in product innovation, combining extensive research capabilities with robust engineering expertise. AWAK Technologies Pte. Ltd. and B. Braun Melsungen AG have further cemented their positions by delivering reliable solutions that enhance patient outcomes. Baxter International Inc. and DaVita Inc. are renowned for integrating comprehensive patient care approaches into their offerings, making significant strides in clinical efficacy and operational efficiency.

Other notable names include Diality, Inc. and Fresenius Medical Care AG & Co. KGaA, which emphasize continuous improvement and technological evolution. Guangzhou MeCan Medical Limited and Infomed SA have effectively bridged the gap between advanced research and practical application, while JMS Co., Ltd. and Kalstein contribute to the market with specialized expertise. KNS MEDICAL SAS and Medtronic PLC stand out as pioneers who are relentlessly pushing the boundaries of innovation in device design, and Mozarc Medical Holding LLC, along with Nephro Care India Limited, have gained respect for their commitment to quality and local market adaptability.

Furthermore, industry trailblazers such as Nikkiso Co., Ltd. and Nipro Corporation have leveraged deep clinical insights to refine their product portfolios, and Outset Medical, Inc. along with Quanta Dialysis Technologies Ltd. are recognized for their forward-thinking approaches in technology integration. Rockwell Medical, Inc. and Shenzhen Landwind Industry Co., Ltd. have carved out significant market niches by focusing on reliability and efficiency, while Soxa Formulations & Research(Pvt.) Ltd., SWS Hemodialysis Care Co., Ltd., Toray Industries, Inc., and Wesley Biotech Co., Ltd. continue to drive competitive excellence with specialized solutions tailored to diverse clinical environments. Together, these companies not only define current market trends but also serve as catalysts for future innovation and enhanced patient care.

The report delves into recent significant developments in the Medical Hemodiafiltration Machine Market, highlighting leading vendors and their innovative profiles. These include ARI Medical Technology Co., Ltd., Asahi Kasei Corporation, AWAK Technologies Pte. Ltd., B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Diality, Inc., Fresenius Medical Care AG & Co. KGaA, Guangzhou MeCan Medical Limited, Infomed SA, JMS Co. Ltd., Kalstein, KNS MEDICAL SAS, Medtronic PLC, Mozarc Medical Holding LLC, Nephro Care India Limited, Nikkiso Co., Ltd., Nipro Corporation, Outset Medical, Inc., Quanta Dialysis Technologies Ltd., Rockwell Medical, Inc., Shenzhen Landwind Industry Co., Ltd., Soxa Formulations & Research(Pvt.) Ltd., SWS Hemodialysis Care Co., Ltd., Toray Industries, Inc., and Wesley Biotech Co., Ltd.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a multifaceted strategic approach that leverages technological innovations, robust clinical studies, and market-specific segmentation insights to advance their market positioning. Leaders should prioritize investing in R&D to drive the creation of more portable and efficient devices, while concurrently enhancing existing systems by integrating components that significantly improve patient safety and treatment efficacy.

It is prudent to develop flexible product lines that cater to diverse end user frameworks, ensuring that trends observed across academic, clinical, and home care settings are addressed through modular design improvements. Performance optimization through iterative testing and collaboration with clinical experts is essential. Furthermore, forging strategic partnerships with regional stakeholders will help in navigating local regulatory frameworks and in tailoring offerings to the unique dynamics of each market. Embracing digital transformation technologies for remote monitoring and predictive maintenance can also greatly enhance operational efficiencies, driving long-term leadership in the sector.

Conclusion: Charting a Future of Innovation and Excellence

In conclusion, the medical hemodiafiltration machine market stands at the intersection of technological innovation and evolving clinical practice. The dynamic landscape shaped by scalable segmentation, rapid technological advancements, and deep regional insights paves the way for a future replete with transformative opportunities. Stakeholders now have the mandate to adopt forward-thinking strategies that address the multifaceted challenges of chronic kidney disease management. By focusing on technological integration, component optimization, and targeted market segmentation, industry leaders can streamline operations and drive superior patient outcomes.

Ultimately, the road ahead hinges on the ability of manufacturers and healthcare providers to innovate continually, scale their solutions globally, and maintain a clear focus on patient-centric care. A cohesive, strategic approach that capitalizes on cutting-edge research and strategic regional positioning is essential to not only meet current demands but to future-proof the industry in an era characterized by constant innovation and evolving healthcare needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about the benefits of hemodiafiltration over traditional dialysis treatments
      • 5.1.1.2. Growing aging population necessitating advanced renal care solutions
      • 5.1.1.3. Rising prevalence of chronic kidney diseases increasing the need for hemodiafiltration
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with machine reliability and technical issues impacting the adoption of hemodiafiltration
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D for the integration of IoT and smart technology within dialysis systems
      • 5.1.3.2. Innovations in hemodiafiltration machine for personalized and home-based dialysis options
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with regulatory compliance and certification of medical hemodiafiltration machines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Portability: Increasing utilization of portable hemodiafiltration machines owing to their flexible and convenient treatment options
    • 5.2.2. End User: Growing adoption of hemodiafiltration machines by dialysis clinics owing to their need for high-volume, efficient, and patient-specific treatment capabilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Hemodiafiltration Machine Market, by Portability

  • 6.1. Introduction
  • 6.2. Portable Hemodiafiltration Machines
  • 6.3. Stationary Hemodiafiltration Machines

7. Medical Hemodiafiltration Machine Market, by Components

  • 7.1. Introduction
  • 7.2. Blood Pumps
  • 7.3. Dialyzer Units
  • 7.4. Hemodiafilter

8. Medical Hemodiafiltration Machine Market, by Modes

  • 8.1. Introduction
  • 8.2. Mid-dilution HDF
  • 8.3. Postdilution HDF
  • 8.4. Predilution HDF

9. Medical Hemodiafiltration Machine Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Dialysis Clinics
  • 9.4. Home Care Settings
  • 9.5. Hospitals

10. Americas Medical Hemodiafiltration Machine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Medical Hemodiafiltration Machine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Medical Hemodiafiltration Machine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA clearance for Quanta's high-flow home hemodialysis system signifies a shift in ESRD care focus towards home treatment
    • 13.3.2. Nephro Care India Limited and NIT Silchar collaborate on cost-effective AI-enabled smart haemodialysis machine to address shortfall in renal care
    • 13.3.3. Fresenius Medical Care advances U.S. dialysis options with FDA-cleared hemodiafiltration technology
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ARI Medical Technology Co., Ltd.
  • 2. Asahi Kasei Corporation
  • 3. AWAK Technologies Pte. Ltd.
  • 4. B. Braun Melsungen AG
  • 5. Baxter International Inc.
  • 6. DaVita Inc.
  • 7. Diality, Inc.
  • 8. Fresenius Medical Care AG & Co. KGaA
  • 9. Guangzhou MeCan Medical Limited
  • 10. Infomed SA
  • 11. JMS Co. Ltd.
  • 12. Kalstein
  • 13. KNS MEDICAL SAS
  • 14. Medtronic PLC
  • 15. Mozarc Medical Holding LLC
  • 16. Nephro Care India Limited
  • 17. Nikkiso Co., Ltd.
  • 18. Nipro Corporation
  • 19. Outset Medical, Inc.
  • 20. Quanta Dialysis Technologies Ltd.
  • 21. Rockwell Medical, Inc.
  • 22. Shenzhen Landwind Industry Co., Ltd.
  • 23. Soxa Formulations & Research(Pvt.) Ltd.
  • 24. SWS Hemodialysis Care Co., Ltd.
  • 25. Toray Industries, Inc.
  • 26. Wesley Biotech Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. MEDICAL HEMODIAFILTRATION MACHINE MARKET MULTI-CURRENCY
  • FIGURE 2. MEDICAL HEMODIAFILTRATION MACHINE MARKET MULTI-LANGUAGE
  • FIGURE 3. MEDICAL HEMODIAFILTRATION MACHINE MARKET RESEARCH PROCESS
  • FIGURE 4. MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. MEDICAL HEMODIAFILTRATION MACHINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. MEDICAL HEMODIAFILTRATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL HEMODIAFILTRATION MACHINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL HEMODIAFILTRATION MACHINE MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABLE HEMODIAFILTRATION MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY STATIONARY HEMODIAFILTRATION MACHINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY BLOOD PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY DIALYZER UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY HEMODIAFILTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MID-DILUTION HDF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY POSTDILUTION HDF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PREDILUTION HDF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY DIALYSIS CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY PORTABILITY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY COMPONENTS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY MODES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM MEDICAL HEMODIAFILTRATION MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. MEDICAL HEMODIAFILTRATION MACHINE MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 192. MEDICAL HEMODIAFILTRATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2024